
AI Low-Dose CT Lung Screening Cuts False Positives 20% in Nigeria
Cureus study on April 15, 2026, validates AI low-dose CT lung cancer screening, advancing Nigerian diagnostics despite infrastructure gaps. Trials show reduced false positives and faster analysis.















